Answer
Lazertinib targets specific abnormal forms of EGFR, so a validated test must confirm an eligible mutation before treatment starts.
Sources for this answer
- Lazcluze 80 mg film-coated tablets — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.